BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35225027)

  • 1. Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension.
    Diao W; Liu G; Shi C; Jiang Y; Li H; Meng J; Shi Y; Chang M; Liu X
    Cell Transplant; 2022; 31():9636897221081479. PubMed ID: 35225027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
    Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
    Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ-
    Zhang J; Li Y; Qi J; Yu X; Ren H; Zhao X; Xin W; He S; Zheng X; Ma C; Zhang L; Wu B; Zhu D
    Hypertension; 2020 Mar; 75(3):668-679. PubMed ID: 32008463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-calm4 regulates hypoxia-induced pulmonary artery smooth muscle autophagy by binding Purb.
    Zhang J; Li Y; Chen Y; Yu X; Wang S; Sun H; Zheng X; Zhang L; Wang Y; Zhu D
    J Mol Cell Cardiol; 2023 Mar; 176():41-54. PubMed ID: 36716953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD.
    Wang C; Liu Y; Zhang W; Huang J; Jiang J; Wang R; Zeng D
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(3):438-448. PubMed ID: 36514216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ-Ntrk2 acts as a miR-296-5p sponge to activate the TGF-β1/p38 MAPK pathway and promote pulmonary hypertension and vascular remodelling.
    Su L; Li X; Mao X; Xu T; Zhang Y; Li S; Zhu X; Wang L; Yao D; Wang J; Huang X
    Respir Res; 2023 Mar; 24(1):78. PubMed ID: 36915149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis.
    Ma H; Yu Y; Mo L; Chen Q; Dong H; Xu Y; Zhuan B
    Aging (Albany NY); 2023 May; 15(9):3549-3571. PubMed ID: 37142272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension.
    Zurlo G; Piquereau J; Moulin M; Pires Da Silva J; Gressette M; Ranchoux B; Garnier A; Ventura-Clapier R; Fadel E; Humbert M; Lemaire C; Perros F; Veksler V
    J Hypertens; 2018 May; 36(5):1164-1177. PubMed ID: 29369849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
    Shi Z; Wu H; Luo J; Sun X
    Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
    Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
    J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
    Zabini D; Granton E; Hu Y; Miranda MZ; Weichelt U; Breuils Bonnet S; Bonnet S; Morrell NW; Connelly KA; Provencher S; Ghanim B; Klepetko W; Olschewski A; Kapus A; Kuebler WM
    Am J Respir Crit Care Med; 2018 Jan; 197(2):244-260. PubMed ID: 29095649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.
    Jing X; Wu S; Liu Y; Wang H; Huang Q
    Bioengineered; 2022 Apr; 13(4):8759-8771. PubMed ID: 35369850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
    Li YX; Run L; Shi T; Zhang YJ
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
    Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P
    FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
    Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
    Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.